Factors influencing psychotropic prescription by non-psychiatrist physicians in a nursing home for the elderly in Brazil

Sao Paulo Medical Journal

Volumn 124, Issue 5, 2006, Pages 253-256

  Stella, Florindo ^a,b   Caetano, Dorgival ^b   Pacheco, Jaime Lisandro ^b   Gasparetto Sé, Elisandra Villela ^b   Tavares Lacerda, Acioly Luiz ^c,d  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d SINAPSE Institute   (Brazil)

Author keywords

Aging; Drug prescriptions; Heart diseases; Homes for the aged; Psychopharmacology

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADULT; AGED; ARTICLE; BRAZIL; CARDIOVASCULAR DISEASE; CORRELATION ANALYSIS; DRUG CONTRAINDICATION; DRUG USE; ELDERLY CARE; FEMALE; FREQUENCY ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NURSING HOME; OBSERVATIONAL STUDY; PRESCRIPTION; SEX DIFFERENCE;

AGE FACTORS; AGED; AGED, 80 AND OVER; BRAZIL; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; DRUG INTERACTIONS; FEMALE; GERIATRIC NURSING; HOMES FOR THE AGED; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; NURSING HOMES; PSYCHOTROPIC DRUGS; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 33846787152     PISSN: 15163180     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-31802006000500003     Document Type: Article

References (25)

1. Snowdon J, Vaughan R, Miller R, Burgess EE, Tremlett P. Psychotropic drug use in Sydney nursing homes. Med J Aust. 1995;163(2):70-2.
2. Katona CL. Psychotropics and drug interactions in the elderly patient. Int J Geriatr Psychiatry. 2001;16 (Suppl 1):S86-90.
3. Buck JA. Psychotropic drug practice in nursing homes. J Am Geriatr Soc. 1988;36(5):409-18.
4. Ruby CM, Kennedy DH. Psychopharmacologic medication use in nursing-home care: Indicators for surveyor assessment of the performance of drug-regimen reviews, recommendations for monitoring, and nonpharmacologic alternatives. Clin Family Practice. 2001;3:577-98.
5. Sorensen L, Foldspang A, Gulmann NC, Munk-Jorgensen P. Determinants for the use of psychotropics among nursing home residents. Int J Geriatr Psychiatry. 2001;16(2):147-54.
6. Robinson MJ, Levenson JL. The use of psychotropics in the medically ill. Curr Psychiatry Rep. 2000;2 (3):247-55.
7. Mort JR, Aparasu RR. Prescribing of psychotropics in the elderly: why is it so often inappropriate? CNS Drugs. 2002;16(2):99-109.
8. Dealberto MJ, Seeman T, McAvay GJ, Berkman L. Factors related to current and subsequent psychotropic drug use in an elderly cohort. J Clin Epidemiol. 1997;50(3):357-64.
9. Fichter MM, Witzke W, Leibl K, Hippius H. Psychotropic drug use in a representative community sample: the Upper Bavarian study. Acta Psychiatr Scand. 1989;80(1):68-77.
10. Nirodi P, Mitchell AJ. The quality of psychotropic drug prescribing in patients in psychiatric units for the elderly. Aging Ment Health. 2002;6(2):191-6.
11. Ancill RJ, Embury GD, MacEwan GW, Kennedy JS. The use and misuse of psychotropic prescribing for elderly psychiatric patients. Can J Psychiatry. 1988;33(7):585-9.
12. Smid J, Nitrini R, Bahia VS, Caramelli P. Caracterização clínica da demência vascular: avaliaçäo retrospectiva de uma amostra de pacientes ambulatoriais. [Clinical characterization of vascular dementia: retrospective evaluation of an outpatient sample]. Arq Neuropsiquiatr. 2001;59(2B):390-3.
13. Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SH. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet. 2000;355(9209):1048-52.
14. Hansen S. Mental health issues associated with cardiovascular disease in women. Psychiatr Clin North Am. 2003; 26(3):693-712.
15. Ryan JM, Kidder SW, Daiello LA, Tariot PN. Psychopharmacologic interventions in nursing homes: what do we know and where should we go? Psychiatr Serv. 2002;53(11):1407-13.
16. Linden M, Lecrubier Y, Bellantuono C, Benkert O, Kisely S, Simon G. The prescribing of psychotropic drugs by primary care physicians: an international collaborative study. J Clin Psychopharmacol. 1999;19 (2):132-40.
17. Linjakumpu T, Hartikainen S, Klaukka T, Koponen H, Kivela SL, Isoaho R. Psychotropics among the home-dwelling elderly - increasing trends. Int J Geriatr Psychiatry. 2002;17(9):874-83.
18. Aparasu RR, Mort JR, Brandt H. Psychotropic prescription use by community-dwelling elderly in the United States. J Am Geriatr Soc. 2003;51(5):671-7.
19. Hohmann AA. Gender bias in psychotropic drug prescribing in primary care. Med Care. 1989;27(5):478-90.
20. Gleason PP, Schulz R, Smith NL, et al. Correlates and prevalence of benzodiazepine use in community-dwelling elderly. J Gen Intern Med. 1998;13(4):243-50.
21. Holmquist IB, Svensson B, Hoglund P. Psychotropic drugs in nursing- and old-age homes: relationships between needs of care and mental health status. Eur J Clin Pharmacol. 2003;59(8-9):669-76.
22. Robins LN, Helzer JE, Weissman MM, et al. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry. 1984;41(10):949-58.
23. van der Waals FW, Mohrs J, Foets M. Sex differences among recipients of benzodiazepines in Dutch general practice. BMJ. 1993;307(6900):363-6.
24. Mellinger GD, Balter MB, Uhlenhuth EH. Prevalence and correlates of the long-term regular use of anxiolytics. JAMA. 1984;251(3):375-9.
25. Verbrugge LM. Gender and health: an update on hypotheses and evidence. J Health Soc Behav. 1985;26 (3):156-82.